Melatonin and Aging: What Science Says About Sleep, Antioxidants, and Longevity

Melatonin is a night-time hormone that helps coordinate sleep and circadian timing; with age, that signal often weakens, which partly explains lighter and more fragmented sleep in older adults.

Public discussion around melatonin usually swings between two bad simplifications: either it is treated as a basic sleep gummy, or it is turned into a molecule that can fix ageing itself. The useful middle ground is this: melatonin matters a great deal for circadian biology, it may offer modest sleep benefits in the right settings, and it has interesting antioxidant and mitochondrial actions. But an interesting mechanism is not the same thing as a proven clinical longevity benefit in humans.

Melatonin sits at the intersection of several themes we cover often at Progevita: mitochondrial dysfunction, inflammaging, epigenetic clocks, sirtuins, and NAD+. What we still do not have is convincing human evidence that taking melatonin extends lifespan or reliably shifts biological ageing markers in a meaningful way.

The 2026 review in Frontiers in Neuroscience captures the field well: melatonin acts as the hormonal signal of darkness, helps maintain circadian synchrony, influences sleep, and also shows antioxidant, neuroprotective, mitochondrial, and immunomodulatory effects (Drăgoi et al., 2026, PMID: 41859230). That same review also exposes the limit of the current evidence. Much of the excitement comes from mechanisms and preclinical work rather than hard clinical outcomes on human longevity.

What melatonin is, and why it changes with age

Melatonin is produced mainly by the pineal gland in response to darkness. It is not best understood as a sedative. Its main role is to tell the body that night has begun. That signal helps coordinate sleep timing, body temperature, hormone rhythms, blood pressure, metabolism, and a range of behaviours tied to the 24-hour light-dark cycle.

That is why melatonin belongs inside circadian medicine, not only inside the supplement aisle. If your internal clock is delayed, if you are exposed to bright light late at night, or if your daily schedule is erratic, melatonin signalling becomes weaker or mistimed. In that setting, poor sleep is often a timing problem before it is a willpower problem.

Endogenous melatonin production tends to decline with age. This was documented decades ago. In 1986, Sack and colleagues showed that human melatonin production, estimated through overnight urinary metabolites, clearly decreased with age (PMID: 3783419). A classic 2005 review by Pandi-Perumal and co-authors concluded that most studies document reduced nocturnal melatonin secretion in ageing populations, alongside poorer sleep continuity and quality (PMID: 16183237).

Dimension	What melatonin does	What often happens with ageing
Circadian timing	Signals biological night	Lower amplitude and a more fragile rhythm
Sleep onset	Helps the body move into night physiology	Longer sleep latency and more awakenings
Hormonal coordination	Supports synchrony across systems	Weaker timing signals
Cellular environment	Shows antioxidant and mitochondrial effects	More oxidative stress and inflammaging

That does not mean every older adult has a clinically meaningful melatonin deficit, and it does not mean every bad night is explained by melatonin alone. Sleep later in life is also shaped by pain, sleep apnoea, nocturia, depression, medication burden, alcohol, caffeine, light exposure, and loss of routine. Melatonin is one piece of the board, not the whole board.

Melatonin, sleep, and circadian rhythm: what expectations are realistic?

If we focus on melatonin for sleep in older adults, the most plausible benefit is a modest reduction in sleep-onset latency and better circadian alignment in selected people. It does not usually behave like a strong hypnotic drug.

The 2021 AAFP review is useful because it puts numbers on the effect. In a meta-analysis of 15 mostly small trials, melatonin reduced sleep-onset latency by about 7.5 minutes, increased total sleep time by 12.8 minutes, and slightly improved sleep efficiency. In prolonged-release melatonin trials using 2 mg in adults aged 65 to 80, sleep-onset latency fell by around 15.6 minutes at three weeks, with adverse event rates similar to placebo (AAFP, 2021).

That is a genuine effect. It is just not a dramatic one. If someone expects melatonin to turn severe insomnia into perfect sleep, disappointment is likely. If someone has a delayed rhythm, too much late-night light exposure, and no regular sleep schedule, melatonin alone will not fix the whole picture either.

The evidence is also not consistent across all groups. The 2022 systematic reviews and meta-analyses in Sleep Medicine Reviews examined 24 randomised trials in chronic insomnia and found that, in adults, melatonin was not significantly effective for sleep-onset latency, total sleep time, or sleep efficiency in a consistent way (Choi et al., 2022, PMID: 36179487). That is one of the most important numbers to keep in mind whenever melatonin is marketed as a general insomnia solution.

None of this makes melatonin useless. It simply places it where it belongs. It may be reasonable for phase delay, jet lag, some sleep-onset problems, some older adults with weaker night-time signalling, or short-term use while light exposure and routines are being corrected. What the evidence does not support is the idea that melatonin is a broad answer to chronic adult insomnia.

Antioxidant actions, mitochondria, and inflammaging: a plausible biological story

The most attractive part of melatonin in longevity medicine is not sleep. It is cell biology. Melatonin can act as a direct free-radical scavenger and may also modulate antioxidant enzymes, mitochondrial function, inflammatory signalling, and immune responses. That is why it keeps showing up in discussions around mitochondrial health, chronic inflammation, cellular senescence, and autophagy.

In animal and cellular models, melatonin appears to reduce oxidative damage, support mitochondrial membranes, and modulate inflammatory mediators. The 2026 review mentioned above frames this clearly: ageing alters melatonin secretion and receptor sensitivity, while declining melatonin signalling is associated with oxidative stress, mitochondrial dysfunction, and inflammaging (PMID: 41859230).

Up to that point, the biological logic is strong. The trouble begins when people jump too fast from “this pathway looks promising” to “this supplement slows ageing”. That jump is still unsupported by good human clinical evidence.

A good example of how to use mechanistic evidence properly is the 2026 paper on mitochondrial drivers of skin ageing (PMID: 41824483). There, melatonin appears as a mitochondria-directed antioxidant with plausible relevance for redox balance and tissue protection. Fine. That supports the idea that melatonin has meaningful cellular actions. It does not prove that taking melatonin capsules will extend human lifespan or broadly slow systemic ageing.

So the cautious summary is straightforward: melatonin has antioxidant and mitochondrial relevance, but that is not the same as a proven human longevity intervention.

Does melatonin slow ageing? What we know and what we do not know

What we know	What we do not know
Melatonin is a core circadian signal and changes with age	Whether long-term supplementation extends human lifespan
It may modestly help sleep onset in selected settings	Which adults with chronic insomnia benefit most in real practice
It shows antioxidant and mitochondrial effects in preclinical work	Whether those mechanisms translate into lower frailty or younger biological age
Short-term use seems reasonably well tolerated for most people	What the long-term safety profile looks like across all patient groups

The cleanest way to think about melatonin is to separate three layers. Layer one: melatonin matters for sleep timing and circadian integrity. Layer two: it has biologically plausible antioxidant, mitochondrial, and inflammatory actions. Layer three: we do not have convincing evidence that supplementing melatonin on its own slows human ageing or increases longevity.

If your goal is to understand biological ageing in a useful clinical way, it makes more sense to measure longevity biomarkers, review sleep quality, body composition, inflammation, and perhaps selected epigenetic clocks. None of that makes melatonin unimportant. It simply reminds us that human ageing is bigger than any one supplement.

When supplementation may make sense, and when it probably does not

There are settings where melatonin supplementation can be reasonable: jet lag, shift work, delayed sleep phase, selected older adults with weak night-time circadian signalling, or short-term support while light exposure and routine are being repaired. In those settings, the aim is not “rejuvenation”. The aim is to improve timing.

It is also worth remembering that more is not automatically better. In practice, clinicians usually start low and adjust. The AAFP review covers studies ranging from 0.1 mg to very high doses, but most patients were in the 1 to 5 mg range, and older-adult prolonged-release trials used 2 mg. Jumping from those data to the assumption that 10 mg or 20 mg must work better is a move beyond the evidence.

When does supplementation make less sense? When it is being used to cover up a problem that deserves diagnosis: sleep apnoea, restless legs, late alcohol intake, poorly timed caffeine, chronic pain, nocturia, depression, or badly managed sedatives. In those cases, melatonin may blur the picture rather than solve it.

At Progevita, we prefer that order: review habits, light exposure, chronotype, stress, medication, and sleep disorders first; then decide whether melatonin fits. At the Balneario de Cofrentes in Valencia, with 50+ medical professionals and programmes such as Leadership Path (from €1,640) and Inflammaging (from €1,470), sleep is never reduced to one capsule. It is linked to VO₂max, body composition, oxidative stress, inflammation, and sustainable routines.

Risks, side effects, and interactions

The fact that melatonin is often seen as “natural” does not make it neutral. The NHS lists several common side effects: daytime sleepiness or tiredness, headache, dizziness, nausea, irritability, and unusual dreams. Most are mild, but if the goal is better sleep and the result is more daytime impairment, the dose, timing, or the whole indication may need to be reconsidered.

Short-term safety looks acceptable for most people. The NCCIH still notes that long-term safety data are limited and that supplements may interact with medicines, especially blood thinners and epilepsy drugs. The NHS gives a practical interaction list that includes warfarin, benzodiazepines, sedating antidepressants such as fluvoxamine or amitriptyline, opioids, blood-pressure medicines, Z-drugs for insomnia, and other sedating remedies.

This matters even more in older adults because polypharmacy is common. If someone is already taking sedatives, blood-pressure medication, or anticoagulants, “trying melatonin on my own” stops being a trivial experiment. Sometimes the issue is not melatonin itself. It is the drug stack around it.

• Most common side effects: daytime drowsiness, headache, dizziness, nausea, vivid dreams.
• Groups needing extra caution: people taking anticoagulants, benzodiazepines, opioids, sedating antidepressants, hypnotics, or epilepsy medication.
• When to ask for medical review: persistent insomnia, suspected sleep apnoea, falls, next-day grogginess, or multiple concurrent medicines.

How to support natural melatonin before reaching for capsules

This is the least glamorous and most useful part. If you want to improve endogenous melatonin, the first move is not to buy a supplement. It is to strengthen the day signal and protect the night signal.

1. Get bright morning light. Go outside soon after waking. Early natural light helps anchor the circadian clock and supports better melatonin release later in the evening. 2. Protect darkness at night. Dim indoor lighting, reduce screen exposure near bedtime, and keep the phone out of bed if possible. 3. Keep regular timing. Going to sleep and waking at roughly the same time matters more than many people expect.

4. Give caffeine a cut-off time. Late afternoon coffee can still affect the night. 5. Be honest about alcohol. It may help with sleep onset while worsening the second half of the night. 6. Finish dinner with enough time. Very late or heavy meals delay night physiology. 7. Move every day. Regular exercise improves sleep, lowers inflammaging, and supports circadian function, though very stimulating sessions right before bed are often a bad idea.

This fits well with the chrononutrition angle discussed in the 2026 review: not only what you eat matters, but also when you eat and what time signals you give the body (PMID: 41859230). That is another reason melatonin should not be isolated from the rest of lifestyle medicine.

How we approach this at Progevita

At Progevita, sleep is not treated as a cosmetic wellness issue. It is one of the main regulators of recovery, inflammatory tone, glucose control, mood, and cognitive performance. So when a patient reports fatigue, poor sleep, or the feeling of “ageing worse”, the first question is not simply whether they are taking melatonin. The real question is what is happening with light exposure, routine, stress, alcohol, exercise, body composition, and biomarkers.

That fits our broader philosophy: measure first, interpret second, intervene third, then re-measure. If oxidative stress looks relevant, the Oxytest and advanced diagnostics help frame that part of the story. If the problem is more about executive stress, circadian disruption, and recovery, Leadership Path puts more attention on sleep, timing, and sustainable behaviour change. If melatonin makes sense after the full review, we use it as one tool, not as the whole explanation.

That is also the difference between a medical longevity programme and shallow biohacking. The goal is not to collect supplements. It is to improve day-to-day biology in a measurable way. If you want to start there, you can start your plan at Progevita.

Frequently asked questions about melatonin and ageing

What is melatonin, and why does it decline with age?

Melatonin is the hormonal signal of darkness. It helps synchronise the circadian clock and supports the transition into night physiology. In many people, nocturnal production declines with age, which may contribute to lighter, more fragmented sleep and weaker circadian stability.

Does melatonin slow ageing?

We do not have strong clinical human evidence showing that it does. Melatonin has biologically plausible antioxidant and mitochondrial actions, but plausible mechanisms are not the same as proven longevity outcomes. Right now the strongest case for melatonin remains sleep and circadian timing.

Does melatonin help older adults sleep better?

It can, especially for sleep onset and circadian timing, but the effect is usually modest. In clinical studies, improvements are often measured in minutes, not hours. If sleep apnoea, pain, alcohol, anxiety, or polypharmacy are present, those issues also need attention.

Which side effects and interactions matter most?

The commonest ones are daytime drowsiness, headache, dizziness, nausea, and vivid dreams. Particular caution is needed with anticoagulants such as warfarin, benzodiazepines, sedating antidepressants, hypnotics, opioids, and epilepsy medication.

How can I support natural melatonin production?

Use bright morning light, protect darkness at night, keep consistent sleep timing, reduce late caffeine, moderate alcohol, avoid very late heavy dinners, and stay physically active. Those basics often move the circadian system more than a supplement used in isolation.

References

1. Drăgoi CM et al. "Rhythms of life: melatonin, nutrition, sleep, and antioxidant strategies for healthy aging." Front Neurosci. 2026. PMID: 41859230.
2. Choi K et al. "Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses." Sleep Med Rev. 2022. PMID: 36179487.
3. Pandi-Perumal SR et al. "Melatonin and sleep in aging population." Exp Gerontol. 2005. PMID: 16183237.
4. Sack RL et al. "Human melatonin production decreases with age." J Pineal Res. 1986. PMID: 3783419.
5. Neher JO, Goebel A. "Melatonin to Treat Insomnia in Older Adults." Am Fam Physician. 2021.
6. NCCIH. "Melatonin: What You Need To Know." Updated 2024.
7. NHS. "Side effects of melatonin" and "Taking melatonin with other medicines and herbal supplements." Reviewed 2023.
8. Antonevich SM et al. "The Mitochondrial Blueprint of Skin Aging: From Damage Signals to Dermatologic Interventions." Aging Dis. 2026. PMID: 41824483.